Nobivac Canine 1 DAPPv+4L 25x1
- Protects against all known strains of canine parvovirus (CPV), including CPV-2c
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies
- The only leptospirosis vaccine to protect and defend against mortality and urinary shedding
- Prevented mortality caused by 4 virulent Leptospira serovars
- Protects against adenovirus type 1 that causes hepatitis in dogs
- Provides disease coverage for commonly spread canine viruses, distemper, adenovirus type 1 (hepatitis), parainfluenza and parvovirus, in 1 formula
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1, parainfluenza, and parvovirus.Indicated as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa.Prevents leptospiruria associated with L. grippotyphosa, L. canicola, or L. icterohaemorrhagiae.Aids in the prevention of leptospiruria associated with L. pomona.Recommended for use in healthy dogs 8 weeks of age or older.
- Subcutaneous injection
- Two 1 mL doses given 2 to 4 weeks apart
- Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
- Annual revaccination with 1 dose is recommended
- Available in a 25 x 1 mL dose presentation